CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05812365
NCT05812365N/ACompleted
CompareCT.gov

Best End-Expiratory and Driving-Pressure for Individualized Flow Controlled Ventilation in Patients With COPD - an Observational Study.

Universitätsklinikum Hamburg-Eppendorf·observational·Posted Apr 13, 2023·Updated Jul 25, 2024

In Brief

An observational study for COPD and 2 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Patients with chronic obstructive pulmonary disease (COPD) have a significantly increased risk of postoperative pulmonary complications (PPC). Protective ventilation of the lungs could reduce the rate of PPC in patients with COPD. It has been suggested that flow controlled ventilation (FCV) may be less invasive and more protective to the lungs than conventional ventilation in patients with COPD. The primary aim of this study is to determine a optimal individual ventilation setting for FCV in ten participants with COPD.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOPD, Ventilator Lung, Anesthesia
CountriesGermany
CollaboratorsVentinova Medical, Eindhoven, Netherlands, Timple SA, Rua Simao Álvares 356 Conj. 41,42 e 51 - Pinheiros, Sao Paulo (Brasilien)

Timeline

N/ACompletedFinished
202420252026
First PostedApr 13, 2023
Enrollment StartJul 1, 2024
Primary CompletionJul 24, 2024
TodayJul 2, 2026
Enrollment to primary: 23 daysPosted 3.2 years ago